# DIFLUPREDNATE
> **ANDA212566** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-03-20
## Drug
- **FDA Application Number:** ANDA212566
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIFLUPREDNATE
- **Generic name:** DIFLUPREDNATE
- **Active ingredients:** DIFLUPREDNATE
- **Dosage form:** EMULSION
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Pharmaceuticals Inc.
- **First approval:** 2025-03-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212566)
---
*MORVS · CC0 1.0*